Palau Science & Technology Journal
SEE OTHER BRANDS

Get your science and technology news from Palau

Palau Science & Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palau Science & Technology Journal.

Press releases published on August 11, 2025

New U.S. Politics Today Op-ed Says VOA Editorials Now Back Trump’s Political Agenda

New U.S. Politics Today Op-ed Says VOA Editorials Now Back Trump’s Political Agenda

WASHINGTON , DC, UNITED STATES, August 11, 2025 /⁨EINPresswire.com⁩/ -- For several decades, Voice of America has been a staple international multimedia broadcaster, known for promoting freedom and democracy in its reporting of news worldwide. But since …

TELA Bio Reports Second Quarter 2025 Financial Results

TELA Bio Reports Second Quarter 2025 Financial Results

MALVERN, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the second quarter ended …

FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update

FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update

Total consideration for the sale of FibroGen China to AstraZeneca now expected to be approximately $210 million, a $50 million increase from initial guidance Net cash held in China at closing now estimated to be approximately $125 million Transaction …

Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights

Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights

Tividenofusp alfa BLA for Hunter syndrome accepted for priority review and assigned PDUFA target action date of January 5, 2026; company preparing for commercial launch DNL126 accelerated approval path for Sanfilippo syndrome Type A aligned with FDA; Phase …

Mercury Systems Reports Fourth Quarter and Fiscal 2025 Results

Mercury Systems Reports Fourth Quarter and Fiscal 2025 Results

Record Q4 FY25 Bookings of $341.5 million; book-to-bill of 1.25 Record backlog of $1.40 billion; up 6% year-over-year Q4 FY25 Revenue of $273.1 million; GAAP net income of $16.4 million; and adjusted EBITDA of $51.3 million Q4 FY25 Operating Cash Flow of $ …

Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

FDA accepts NDA submission for Anaphylm™; PDUFA date set for January 31, 2026 Planning continues for a Q1 2026 U.S. launch of Anaphylm, if approved by the FDA Company accelerates Anaphylm global expansion strategy to Canada and the EU Company to host …

Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results

Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results

Advancing Selection of Next-Generation Oral Small Molecule PTH1R Agonist for Clinical Development Initiating Phase 1 Trial for SEP-631, MRGPRX2 NAM Program, for Mast Cell Diseases Updated Cash Runway Expected to Support Operating Plans at Least into 2029 …

Gyre Therapeutics Reports Second Quarter 2025 and Year-to-Date Financial Results and Provides Business and Leadership Update

Gyre Therapeutics Reports Second Quarter 2025 and Year-to-Date Financial Results and Provides Business and Leadership Update

 Net income of $1.6 million and $5.3 million for the three and six months ended June 30, 2025, respectively; reaffirms full-year revenue guidance of $118-128 million Ping Zhang, Executive Chairman, appointed interim CEO as Dr. Han Ying transitions to …

Harrow Announces Second-Quarter 2025 Financial Results

Harrow Announces Second-Quarter 2025 Financial Results

Second-Quarter 2025 and Recent Selected Highlights: Total revenues of $63.7 million, a 30% increase over $48.9 million recorded in the prior-year period GAAP net income of $5.0 million Adjusted EBITDA of $17.0 million Cash and cash equivalents of $53.0 …

Rapid7 to Participate in Upcoming Investor Conferences

Rapid7 to Participate in Upcoming Investor Conferences

BOSTON, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, today announced that the company will be attending the following conferences: The Canaccord Genuity 45th Annual Growth Conference in …

Inventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference

Inventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference

Daix (France), New York City (New York, United States), August 11, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment …

Inventiva Participera à la « Canaccord Genuity 45th Annual Growth Conference »

Inventiva Participera à la « Canaccord Genuity 45th Annual Growth Conference »

Daix (France), New York City (New York, Etats-Unis), le 11 aout 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de la …

DarkIris Inc. Announces Closing of Initial Public Offering

DarkIris Inc. Announces Closing of Initial Public Offering

Hong Kong, Aug. 11, 2025 (GLOBE NEWSWIRE) -- DarkIris Inc. (Nasdaq: DKI) (the “Company” or “DarkIris”), a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games through various third-party digital …

Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion

Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion

WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), reiterates investor confidence and estimated asset value over $10 billion. In October 2024, HMP Partners and The Patel Family LLP, …

Balltze, the Bonk Dog, Launches Today on Solana — Created by the Legendary MYRO Deployer

Balltze, the Bonk Dog, Launches Today on Solana — Created by the Legendary MYRO Deployer

Dubai, UAE, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Ready, set, bonk! Today marks the official launch and live trading of Balltze ($BALLTZE), the latest meme coin to capture internet culture—directly inspired by the Cheems legend—deployed by the mastermind who …

Umbra Launches New Space Systems Business Unit with Flight-Proven, American-Made Hardware for Operators Worldwide

Umbra Launches New Space Systems Business Unit with Flight-Proven, American-Made Hardware for Operators Worldwide

Salt Lake City, Utah, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Umbra, a leading American space technology company, announced today the official launch of its new Space Systems business unit at the Small Satellite Conference in Salt Lake City, Utah. This strategic …

Matrix-Game 2.0 Released: The First Open-Source Interactive World Model for Real-Time Long-Sequence Generation

Matrix-Game 2.0 Released: The First Open-Source Interactive World Model for Real-Time Long-Sequence Generation

Singapore, Aug. 11, 2025 (GLOBE NEWSWIRE) -- On August 12, Skywork AI announced the release of Matrix-Game 2.0, the upgraded version of its Matrix series interactive world model. This breakthrough model delivers real-time, long-sequence interactive video …

Evercommerce to Present at Third Quarter Investor Conferences

Evercommerce to Present at Third Quarter Investor Conferences

DENVER, Aug. 11, 2025 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, today announced that management will present at the following upcoming investor conferences: Chief Executive Officer Eric …

REPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion

REPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion

Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2. Forecast adds to Tevogen Bio's Oncology therapeutic area projections of $1 billion in the launch year and $10–$14 billion over the first five years. WARREN, N.J., Aug. 11, 2025 ( …

Sparkeey Joins British Beauty Council

Sparkeey Joins British Beauty Council

Photo Courtesy of: Sparkeey LONDON, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Sparkeey is delighted to announce it has joined as a Patron of the British Beauty Council. This milestone marks a step forward in the mission to redefine how Gen Z and Gen Alpha …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions